In This Section

News Detail

P. Jeffrey Conn of Vanderbilt spurs collaboration between academia and industry at Academic Drug Discovery Conference

December 05, 2013

P. Jeffrey ConnIn October, P. Jeffrey Conn, Ph.D., Professor and Director of the Vanderbilt University Program in Drug Discovery, wrote an article entitled "United effort is our best hope" for The Tennessean regarding the 2013 Academic Drug Discovery and Life Science Tennessee combined conference held in Nashville, TN. Dr. Conn, co-founder of the Academic Drug Discovery Consortium, wrote about the aim of the conference which was to stimulate collaborative efforts between academia and industry in biomedical research and ultimately produce more successful and cost-effective drug development processes. The article is no longer available, but information about the Academic Drug Discovery Consortium can be found online at: http://www.addconsortium.org/.

Dr. Conn serves as a delegate to the International Union of Basic and Clinical Pharmacology (IUPHAR). He is a previous recipient of Pharmacia-ASPET Award for Experimental Therapeutics and the ASPET-Astellas Award in Translational Pharmacology, having received both in 2007.

Related Files:
Categories:
  • Members in the News

Job Postings